A rare RET gene exon 8 mutation is found in two Greek kindreds with familial medullary thyroid carcinoma: Implications for screening

Clinical Endocrinology

Volumn 64, Issue 5, 2006, Pages 561-566

  Kaldrymides, Philippos ^a   Mytakidis, Nikolaos ^a   Anagnostopoulos, Theodore ^b   Vassiliou, Manolis ^a   Tertipi, Athanasia ^a   Zahariou, Maria ^a   Rampias, Theodoros ^c   Koutsodontis, Giorgos ^c   Konstantopoulou, Irene ^c   Ladopoulou, Angela ^c   Bei, Thalia ^c   Yannoukakos, Drakoulis ^b  

^a METAXA CANCER HOSPITAL   (Greece)

^b INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^c Biogenomica   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN RET;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DNA SEQUENCE; EXON; FAMILY STUDY; FEMALE; GENE MUTATION; GERM LINE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MALE; ONCOGENE RET; PRIORITY JOURNAL; PROTO ONCOGENE; SCREENING; THYROID MEDULLARY CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, MEDULLARY; CONSANGUINITY; DNA MUTATIONAL ANALYSIS; EXONS; FEMALE; GENETIC SCREENING; GREECE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; PEDIGREE; POINT MUTATION; PROTO-ONCOGENE PROTEINS C-RET; PROTO-ONCOGENES; THYROID NEOPLASMS;

EID: 33646015994     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2006.02509.x     Document Type: Article

References (23)

1. Marx S.J. 2005 Molecular genetics of multiple endocrine neoplasia types 1 and 2. Nature Reviews of Cancer 5 367 375.
2. Mulligan L.M. Eng C. Healey C.S. Clayton D. Kwok J.B. Gardner E. Ponder M.A. Frilling A. Jackson C.E. Lehnert H. Neumann H.P.H. Thibodeau S.N. Ponder B.A.J. 1994 Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nature Genetics 6 70 74.
3. Leboulleux S. Baudin E. Travagli J.P. Schlumberger M. 2004 Medullary thyroid carcinoma. Clinical Endocrinology 61 299 310.
4. Marx S.J. Simonds W.F. 2005 Hereditary hormone excess: genes, molecular pathways, and syndromes. Endocrine Reviews 26 615 661.
5. Hansford J.R. Mulligan L.M. 2000 Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis. Journal of Medical Genetics 37 817 827.
6. Kouvaraki M.A. Shapiro S.E. Perrier N.D. Cote G.J. Gagel R.F. Hoff A.O. Sherman S.I. Lee J.E. Evans D.B. 2005 RET proto-oncogene: a review and update of genotype-phenotype correlations in hereditary medullary thyroid cancer and associated endocrine tumors. Thyroid 15 531 544.
7. Farndon J.R. Leight G.S. Dilley W.G. Baylin S.B. Smallridge R.C. Harrison T.S. Wells S.A. Jr. 1986 Familial medullary thyroid carcinoma without associated endocrinopathies: a distinct clinical entity. British Journal of Surgery 73 278 281.
8. Pigny P. Bauters C. Wemeau J.L. Houcke M.L. Crepin M. Caron P. Giraud S. Calender A. Buisine M.P. Kerckaert J.P. Porchet N. 1999 A novel 9-base pair duplication in RET exon 8 in familial medullary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 84 1700 1704.
9. Da Silva A.M. Maciel R.M. Da Silva M.R. Toledo S.R. De Carvalho M.B. Cerutti J.M. 2003 ) A novel germ-line point mutation in RET exon 8 (Gly(533)Cys) in a large kindred with familial medullary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 88 5438 5443.
10. Machens A. Ukkat J. Brauckhoff M. Gimm O. Dralle H. 2005 Advances in the management of hereditary medullary thyroid cancer. Journal of Internal Medicine 257 50 59.
11. Jindrichova S. Vcelak J. Vlcek P. Neradilova M. Nemec J. Bendlova B. 2004 Screening of six risk exons of the RET proto-oncogene in families with medullary thyroid carcinoma in the Czech Republic. Journal of Endocrinology 183 257 265.
12. Berndt I. Reuter M. Saller B. Frank-Raue K. Groth P. Grussendorf M. Raue F. Ritter M.M. Hoppner W. 1998 A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A. Journal of Clinical Endocrinology and Metabolism 83 770 774.
13. Brandi M.L. Gagel R.F. Angeli A. Bilezikian J.P. Beck-Peccoz P. Bordi C. Conte-Devolx B. Falchetti A. Gheri R.G. Libroia A. Lips C.J. Lombardi G. Mannelli M. Pacini F. Ponder B.A. Raue F. Skogseid B. Tamburrano G. Thakker R.V. Thompson N.W. Tomassetti P. Tonelli F. Wells S.A. Marx S.J. 2001 Guidelines for diagnosis and therapy of MEN type 1 and type 2. Journal of Clinical Endocrinology and Metabolism 86 5658 5671.
14. Lesueur F. Cebrian A. Cranston A. Leyland J. Faid T.M. Clements M.R. Robledo M. Whittaker J. Ponder B.A. 2005 Germline homozygous mutations at codon 804 in the RET protooncogene in medullary thyroid carcinoma/multiple endocrine neoplasia type 2A patients. Journal of Clinical Endocrinology and Metabolism 90 3454 3457.
15. Lombardo F. Baudin E. Chiefari E. Arturi F. Bardet S. Caillou B. Conte C. Dallapiccola B. Giuffrida D. Bidart J.M. Schlumberger M. Filetti S. 2002 Familial medullary thyroid carcinoma: clinical variability and low aggressiveness associated with RET mutation at codon 804. Journal of Clinical Endocrinology and Metabolism 87 1674 1680.
16. Cebrian A. Lesueur F. Martin S. Leyland J. Ahmed S. Luccarini C. Smith P.L. Luben R. Whittaker J. Pharoah P.D. Dunning A.M. Ponder B.A.J. 2005 Polymorphisms in the initiators of RET (rearranged during transfection) signaling pathway and susceptibility to sporadic medullary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 90 6268 6274.
17. Robledo M. Gil L. Pollan M. Cebrian A. Ruiz S. Azanedo M. Benitez J. Menarguez J. Rojas J.M. 2003 Polymorphisms G691S/S904S of RET as genetic modifiers of MEN 2A. Cancer Research 63 1814 1817.
18. Huang S.C. Koch C.A. Vortmeyer A.O. Pack S.D. Lichtenauer U.D. Mannan P. Lubensky I.A. Chrousos G.P. Gagel R.F. Pacak K. Zhuang Z. 2000 Duplication of the mutant RET allele in trisomy 10 or loss of the wild-type allele in multiple endocrine neoplasia type 2-associated pheochromocytomas. Cancer Research 60 6223 6226.
19. Huang S.C. Torres-Cruz J. Pack S.D. Koch C.A. Vortmeyer A.O. Mannan P. Lubensky I.A. Gagel R.F. Zhuang Z. 2003 Amplification and overexpression of mutant RET in multiple endocrine neoplasia type 2-associated medullary thyroid carcinoma. Journal of Clinical Endocrinology and Metabolism 88 459 463.
20. Lecube A. Hernandez C. Oriola J. Galard R. Gemar E. Mesa J. Simo R. 2002 V804M RET mutation and familial medullary thyroid carcinoma: report of a large family with expression of the disease only in the homozygous gene carriers. Surgery 131 509 514.
21. Elisei R. Cosci B. Romei C. Agate L. Piampiani P. Miccoli P. Berti P. Basolo F. Ugolini C. Ciampi R. Nikiforov Y. Pinchera A. 2004 Identification of a novel point mutation in the RET gene (Ala883Thr), which is associated with medullary thyroid carcinoma phenotype only in homozygous condition. Journal of Clinical Endocrinology and Metabolism 89 5823 5827.
22. Karga H.J. Karayianni M.K. Linos D.A. Tseleni S.C. Karaiskos K.D. Papapetrou P.D. 1998 Germ line mutation analysis in families with multiple endocrine neoplasia type 2A or familial medullary thyroid carcinoma. European Journal of Endocrinology 139 410 415.
23. Alevizaki M. Sarika H. Koutras D.A. Souvatzoglou A. 1997 Genetic screening for RET mutations in families with multiple endocrine neoplasia 2 syndromes. Annals of the New York Academy of Sciences 816 383 388.